Ardelyx ARDX Accrued payments due to AstraZeneca
Accrued payments due to AstraZeneca at other companies
Other financials
Where this comes from
Reported directly by Ardelyx in its filing.
Tagged under the XBRL concept ardx:AccruedPaymentsDueToThirdParty.
The official record: Ardelyx’s 10-K, filed February 19, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ardelyx's accrued payments due to astrazeneca.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ardelyx's accrued payments due to astrazeneca?
- Ardelyx (ARDX) reported accrued payments due to astrazeneca of $0 in Q4 2025.
- What is the long-term trend for Ardelyx's accrued payments due to astrazeneca?
- Over 3 years (2022 to 2025), Ardelyx's accrued payments due to astrazeneca has grown at a -100.0% compound annual growth rate (CAGR), from $3.39M to $0.
- What does accrued payments due to astrazeneca mean?
- The outstanding financial obligations owed to third-party partners, such as licensors or collaborators, arising from contractual agreements. These payments often relate to milestone achievements, royalty obligations, or shared development costs. This metric highlights the company's ongoing financial commitments to external entities that support its product pipeline.